D E Kern

2.3k citations

21 papers · 1.9k indexed · 1 hit paper · h-index 15

Impact in

Immunology top 2%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Response and Inflammation
Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers

Papers in ⓘ

Immunology 16
- Immunotherapy and Immune Responses 10
- Immune Cell Function and Interaction 8
- T-cell and B-cell Immunology 4
Oncology 11
- CAR-T cell therapy research 8

Co-authors: Steven Gillis (5 shared papers)Christopher S. Henney (2 shared papers)Kagemasa Kuribayashi (1 shared paper)Martin A. Cheever (9 shared papers)P D Greenberg (4 shared papers)Philip D. Greenberg (10 shared papers)K Kuribayashi (1 shared paper)J Klarnet (7 shared papers)
Journals: The Journal of Immunology (11 papers)The Journal of Experimental Medicine (2 papers)Mechanisms of Ageing and Development (2 papers)Nature (1 paper)Progress in tumor research (1 paper)
Partner nations: United States South Africa Canada

In The Last Decade

D E Kern

21 papers receiving 1.8k citations

Hit Papers

align trajectories log scale

Interleukin-2 augments natural killer cell activity 1981 · 776 citations

Peers

Countries citing papers authored by D E Kern

Since Specialization

Citations

This map shows the geographic impact of D E Kern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D E Kern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D E Kern more than expected).

Fields of papers citing papers by D E Kern

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D E Kern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D E Kern. The network helps show where D E Kern may publish in the future.

Co-authors

The 25 scholars most cited alongside D E Kern, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D E Kern Line = papers co-authored together D E Kern links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Interleukin-2 augments natural killer cell activity Nature ·Christopher S. Henney, Kagemasa Kuribayashi, D E Kern, Steven Gillis Hit paper breakdown →	1981	776
2	Murine NK cell cultures: effects of interleukin-2 and interferon on cell growth and cytotoxic reactivity. The Journal of Immunology ·K Kuribayashi, Steven Gillis, D E Kern, Christopher S. Henney	1981	256
3	Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells. The Journal of Experimental Medicine ·P D Greenberg, D E Kern, Martin A. Cheever	1985	246
4	The role of interleukin-2 (IL-2) in the differentiatin of cytotoxic T cells: the effect of monoclonal anti-IL-2 antibody and absorption with IL-2 dependent T cell lines. The Journal of Immunology ·D E Kern, Steven Gillis, Masaji Okada, C S Henney	1981	100
5	Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL. The Journal of Immunology ·D E Kern, J Klarnet, Michael C. Jensen, Philip D. Greenberg	1986	88
6	Eradication of disseminated murine leukemia by treatment with high-dose interleukin 2. The Journal of Immunology ·John A. Thompson, David Peace, J Klarnet, D E Kern, P D Greenberg, Martin A. Cheever	1986	84
7	Interleukin 2 (IL 2) administered in vivo: influence of IL 2 route and timing on T cell growth. The Journal of Immunology ·Martin A. Cheever, John A. Thompson, D E Kern, Philip D. Greenberg	1985	67
8	FBL-reactive CD8+ cytotoxic and CD4+ helper T lymphocytes recognize distinct Friend murine leukemia virus-encoded antigens. The Journal of Experimental Medicine ·J Klarnet, D E Kern, Kiyotaka Okuno, Curtis A. Holt, F Lilly, Philip D. Greenberg	1989	61
9	IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes. The Journal of Immunology ·David Peace, D E Kern, Kirk R. Schultz, P D Greenberg, Martin A. Cheever	1988	42
10	Antigen-driven T cell clones can proliferate in vivo, eradicate disseminated leukemia, and provide specific immunologic memory. The Journal of Immunology ·J Klarnet, L A Matis, D E Kern, M T Mizuno, David Peace, Julie Thompson, Philip D. Greenberg, Martin A. Cheever	1987	38
11	Helper-independent CD8+ cytotoxic T lymphocytes express IL-1 receptors and require IL-1 for secretion of IL-2. The Journal of Immunology ·J Klarnet, D E Kern, Steven Dower, L A Matis, Martin A. Cheever, Philip D. Greenberg	1989	29
12	Induction of lymphokine-activated killer activity by interleukin 4 in human lymphocytes preactivated by interleukin 2 in vivo or in vitro. PubMed ·Carl M. Higuchi, John A. Thompson, Catherine Lindgren, Steven Gillis, Michael B. Widmer, D E Kern, Alexander Fefer	1989	26
13	Analysis of T-Cell Receptor Gene Rearrangement in Lymph Nodes of Patients With Mycosis Fungoides Archives of Dermatology ·D E Kern, Pamela G. Kidd, Roger E. Moe, Deena Hanke, John E. Olerud	1998	23
14	Lyt-2+ cells. Requirements for concanavalin A-induced proliferation and interleukin 2 production. The Journal of Immunology ·D E Kern, L B Lachmann, Philip D. Greenberg	1987	18
15	Enhancement by interleukin 4 of interleukin 2- or antibody-induced proliferation of lymphocytes from interleukin 2-treated cancer patients. PubMed ·Jonathan Treisman, Carl M. Higuchi, John A. Thompson, Steven Gillis, Catherine Lindgren, D E Kern, Stanley R. Ridell, Philip D. Greenberg, Alexander Fefer	1990	14
16	Il-4 is an endogenous T cell growth factor during the immune response to a syngeneic retrovirus-induced tumor. The Journal of Immunology ·D E Kern, David Peace, J Klarnet, Martin A. Cheever, Philip D. Greenberg	1988	12
17	Interleukin-2 administered in vivo induces the growth and augments the function of cultured T cells in vivo. PubMed ·Martin A. Cheever, John A. Thompson, D E Kern, Philip D. Greenberg	1984	5
18	Identification of a unique T cell-derived lymphokine that primes macrophages for tumor cytotoxicity. The Journal of Immunology ·D E Kern, K H Grabstein, Kiyotaka Okuno, Robert D. Schreiber, P D Greenberg	1989	4
19	Therapy of Disseminated Tumors by Adoptive Transfer of Specifically Immune T Cells1 Progress in tumor research ·Philip D. Greenberg, J Klarnet, D E Kern, Martin A. Cheever	2015	2
20	Relationship between in vivo mitomycin c exposure, sister chromatid exchange induction and in vitro mitogenic proliferation. II. Effect of aging on spleen cell mitogenesis and sister chromatid exchange induction Mechanisms of Ageing and Development ·P MANN, D E Kern, David E. Kram, E SCHNEIDER	1981	2

About D E Kern

D E Kern is a scholar working on Immunology, Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Genetics, having authored 21 papers that have together received 1.9k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (10 papers), CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (8 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), T-cell and B-cell Immunology (4 papers), Virus-based gene therapy research (3 papers), DNA Repair Mechanisms (2 papers) and Carcinogens and Genotoxicity Assessment (2 papers). The work is most often cited by research in Immunology (1.5k citations), Oncology (556 citations), Radiology, Nuclear Medicine and Imaging (342 citations), Hematology (113 citations) and Virology (39 citations). D E Kern has collaborated with scholars based in United States, South Africa and Canada. Frequent co-authors include Steven Gillis, Christopher S. Henney, Kagemasa Kuribayashi, Martin A. Cheever, P D Greenberg, Philip D. Greenberg, K Kuribayashi, J Klarnet, John A. Thompson and David Peace. Their work appears in journals such as The Journal of Immunology, The Journal of Experimental Medicine, Mechanisms of Ageing and Development, Nature and Progress in tumor research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact